White Paper

What Is The Cost Of Not Doing MES?

Source: Koerber Pharma Software

“If you need to do an ROI study, then perhaps MES is not for you ...!” goes a provocative comment from a consultant when positioning to management the benefits of Manufacturing Execution Systems (MES). In this age of digitization, many pharma and biotech companies still struggle to gain senior level buy-in for investments in manufacturing IT. Whilst corporate IT initiatives such as Enterprise Resource Planning (ERP) are well understood and seen as ‘nobrainers’, not believing in a Return On Investment (ROI) for manufacturing solutions is a major reason why companies still struggle to eliminate paper GxP records and modernize systems.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene